Treatment of osteoporosis with TheraCyte-encapsulated parathyroid cells: a study in a rat model
Authors:
- 5 April 2006
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 17 (6) , 936-941
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A high body mass index protects against femoral neck osteoporosis in healthy elderly subjectsNutrition, 2004
- Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal OsteoporosisThe Journal of Clinical Endocrinology & Metabolism, 2003
- Short‐term immunosuppression after rat parathyroid allotransplantationMicrosurgery, 2003
- Short-Term, High-Dose Parathyroid Hormone-Related Protein as a Skeletal Anabolic Agent for the Treatment of Postmenopausal OsteoporosisThe Journal of Clinical Endocrinology & Metabolism, 2003
- Commentary on Clinical Safety of Recombinant Human Parathyroid Hormone 1-34 in the Treatment of Osteoporosis in Men and Postmenopausal WomenJournal of Bone and Mineral Research, 2002
- Xenotransplantation of parathyroids in rats using barium-alginate and polyacrylic acid multilayer microcapsulesExperimental and Toxicologic Pathology, 2001
- Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2001
- Microencapsulation of Human Parathyroid Cells: An “in Vitro” StudyJournal of Surgical Research, 2001
- Cryopreserved human parathyroid tissue: cell cultures for in vitro testing of functionTransplantation Proceedings, 2001
- The effect of cryopreservation on parathyroid cell viability and functionThe American Journal of Surgery, 1997